Diagnostic options · UAE

Genetic tests in Dubai & UAE

Compare available Genetic tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

805

Listed price range

600.00–30,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Genetic test prices

Showing 361–375 of 805 matching tests.

Genetic diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-3564 IARS2 Gene Genetic Test for Syndromic Disorders This test evaluates the IARS2 gene for mutations associated with a specific syndromic disorder.	Peripheral Whole Blood	3–4 Weeks (after sample receipt)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["IARS2 gene sequence", "Copy Number Variants (CNVs) in IARS2 gene"] Parameters [] Preparation ["Ensure a valid referral from a specialist", "Avoid sample collection during acute febrile illness", "Inform phlebotomist of anticoagulant therapy or bleeding disorder", "Signed informed consent required (parental consent for minors)"] Indications ["Suspected IARS2-related syndromic disease", "Family history of IARS2-related syndromic disease"] Measurement technique Confirm with laboratory Codes LOINC: 91253-3 ICD-10: Q87.8 Clinical summary This test evaluates the IARS2 gene for mutations associated with a specific syndromic disorder.
TEST-3866 IARS2 Gene‑Related Disorders Genetic Test This test identifies pathogenic variants in the IARS2 gene associated with a multisystem disorder.	Peripheral Whole Blood	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the IARS2 gene"] Parameters [] Preparation ["No fasting required", "No medication cessation required"] Indications ["Individuals presenting with a clinical spectrum suggestive of IARS2-related disorder", "Confirmation of suspected IARS2 gene mutation"] Measurement technique Confirm with laboratory Codes LOINC: 94222-2 ICD-10: E71.1 Clinical summary This test identifies pathogenic variants in the IARS2 gene associated with a multisystem disorder.
TEST-1484 IDH1 & IDH2 Mutation Analysis Test This test detects specific somatic mutations in the IDH1 and IDH2 genes within tumor tissue.	Formalin-Fixed Paraffin-Embedded (FFPE) Tumor Tissue	7–8 Working Days	1,600.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Somatic point mutations in IDH1 gene", "Somatic point mutations in IDH2 gene"] Parameters [] Preparation [] Indications ["Diagnosis of gliomas", "Diagnosis of acute myeloid leukemia (AML)", "Diagnosis of chondrosarcomas", "Diagnosis of select cholangiocarcinomas", "Prognosis determination", "Targeted therapy stratification"] Measurement technique Confirm with laboratory Codes LOINC: ['92814-3', '92815-0'] ICD-10: ['C71.9', 'C92.00'] Clinical summary This test detects specific somatic mutations in the IDH1 and IDH2 genes within tumor tissue.
TEST-3751 IFIH1 Gene Aicardi-Goutières Syndrome Type 7 Genetic Test This test evaluates the IFIH1 gene for pathogenic variants associated with Aicardi-Goutières syndrome type 7.	Peripheral whole blood, extracted DNA, or dried blood spot	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["IFIH1 gene sequence", "Pathogenic variants (SNVs, indels, CNVs)"] Parameters [] Preparation ["Mandatory pre-test genetic counselling session", "Provide family history/pedigree chart"] Indications ["Suspected Aicardi-Goutières syndrome type 7", "Family history of Aicardi-Goutières syndrome"] Measurement technique Confirm with laboratory Codes LOINC: 81304-0 ICD-10: G04.1 Clinical summary This test evaluates the IFIH1 gene for pathogenic variants associated with Aicardi-Goutières syndrome type 7.
TEST-5348 IFNGR2 Gene (Atypical Mycobacterial Infection) Genetic Test This genetic test identifies pathogenic variants in the IFNGR2 gene associated with Mendelian susceptibility to mycobacterial disease (MSMD). It helps diagnose individuals with ext...	Whole blood (EDTA), extracted genomic DNA, or dried blood spot (FTA card)	3 – 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the IFNGR2 gene", "Full exon coverage including splice-site regions"] Parameters [] Preparation ["Mandatory Pre-test Genetic Counseling required.", "Written consent from a legal guardian is mandatory for individuals under 18 years."] Indications ["Diagnosis of Mendelian susceptibility to mycobacterial disease (MSMD)", "Family risk assessment for MSMD", "Guiding targeted antimicrobial prophylaxis"] Measurement technique Confirm with laboratory Codes LOINC: 81247-9 ICD-10: D84.8 Clinical summary This genetic test identifies pathogenic variants in the IFNGR2 gene associated with Mendelian susceptibility to mycobacterial disease (MSMD). It helps diagnose individuals with extreme susceptibility to atypical mycobacterial infections.
TEST-2935 IFT122 Gene Cranioectodermal Dysplasia Type 1 Genetic Test This test evaluates the IFT122 gene for pathogenic variants associated with Cranioectodermal Dysplasia Type 1.	Whole blood (EDTA) or FTA card	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["IFT122 gene sequence", "Copy number variants in IFT122"] Parameters [] Preparation ["No specific fasting required", "Do not discontinue prescribed medication"] Indications ["Suspected Cranioectodermal Dysplasia Type 1 (Sensenbrenner syndrome)", "Family history of the disorder"] Measurement technique Confirm with laboratory Codes LOINC: 82939-0 ICD-10: Q87.8 Clinical summary This test evaluates the IFT122 gene for pathogenic variants associated with Cranioectodermal Dysplasia Type 1.
TEST-2932 IFT43 Gene Cranioectodermal Dysplasia Type 3 Genetic Test This test identifies pathogenic variants in the IFT43 gene, confirming a diagnosis of cranioectodermal dysplasia type 3.	Peripheral Whole Blood (EDTA tube)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["IFT43 gene coding region variants", "Pathogenic mutations"] Parameters [] Preparation ["Inform physician of all medications before testing"] Indications ["Children with characteristic facial dysmorphism, skeletal anomalies, and ectodermal defects", "Suspected cranioectodermal dysplasia type 3"] Measurement technique Confirm with laboratory Codes LOINC: 82939-0 ICD-10: Q87.89 Clinical summary This test identifies pathogenic variants in the IFT43 gene, confirming a diagnosis of cranioectodermal dysplasia type 3.
TEST-2309 IFT80 Gene Short-Rib Thoracic Dysplasia Type 2 with or without Polydactyly Genetic Test This test evaluates the IFT80 gene for mutations associated with Short-Rib Thoracic Dysplasia Type 2 (SRTD2), a rare skeletal dysplasia.	Peripheral whole blood or buccal swab	3–4 Weeks (Expedited available)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the IFT80 gene", "Coding regions and splice sites of the IFT80 gene"] Parameters [] Preparation ["No specific fasting required", "Do not discontinue prescribed medication without consulting physician"] Indications ["Clinical suspicion of Short-Rib Thoracic Dysplasia Type 2 (SRTD2)", "Confirmed family history of SRTD2", "Need for accurate diagnosis for prognosis and management", "Reproductive planning and genetic counseling"] Measurement technique Confirm with laboratory Codes LOINC: 81337-7 ICD-10: Q77.2 Clinical summary This test evaluates the IFT80 gene for mutations associated with Short-Rib Thoracic Dysplasia Type 2 (SRTD2), a rare skeletal dysplasia.
TEST-1493 IgH Gene Rearrangement by FISH for Multiple Myeloma (MM) Test This diagnostic test evaluates chromosomal rearrangements within the immunoglobulin heavy chain (IgH) gene locus.	Bone marrow aspirate or peripheral blood	3–4 working days	700.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Immunoglobulin heavy chain (IgH) gene rearrangements", "Chromosomal translocations"] Parameters [] Preparation ["No specific fasting required", "Inform physician about all medications"] Indications ["Suspected multiple myeloma", "Diagnosis of plasma cell neoplasms", "Risk stratification", "Minimal residual disease monitoring"] Measurement technique Confirm with laboratory Codes LOINC: 49901-1 ICD-10: C90.0 Clinical summary This diagnostic test evaluates chromosomal rearrangements within the immunoglobulin heavy chain (IgH) gene locus.
TEST-5360 IGHMBP2 Gene Distal Hereditary Motor Neuropathy Type 6 (dHMN6/SMARD1) Genetic Test This genetic test evaluates the IGHMBP2 gene for variants associated with distal hereditary motor neuropathy type 6 (dHMN6) and severe spinal muscular atrophy with respiratory dist...	Peripheral Blood (Whole Blood)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["IGHMBP2 gene sequence", "Copy Number Variations (CNV) in IGHMBP2 gene"] Parameters [] Preparation [] Indications ["Clinical features of distal motor weakness", "Suspected hereditary neuropathy", "Family history of IGHMBP2-related disorders"] Measurement technique Confirm with laboratory Codes LOINC: 21673-8 ICD-10: G60.0 Clinical summary This genetic test evaluates the IGHMBP2 gene for variants associated with distal hereditary motor neuropathy type 6 (dHMN6) and severe spinal muscular atrophy with respiratory distress type 1 (SMARD1).
TEST-4895 IKBKG Gene (NEMO) Immunodeficiency Genetic Test This genetic test identifies pathogenic variants in the IKBKG gene (NEMO) associated with specific immunodeficiency disorders and related conditions.	Whole blood (EDTA), extracted DNA, or FTA card blood spot	3 – 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["IKBKG gene variants", "Pathogenic mutations"] Parameters [] Preparation [] Indications ["Suspected Incontinentia Pigmenti", "Suspected Hypohidrotic Ectodermal Dysplasia with Immunodeficiency", "Family history of IKBKG-related disorders", "Evaluation of primary immunodeficiency"] Measurement technique Confirm with laboratory Codes LOINC: 81247-9 ICD-10: Q82.3, D82.8 Clinical summary This genetic test identifies pathogenic variants in the IKBKG gene (NEMO) associated with specific immunodeficiency disorders and related conditions.
TEST-4878 IKBKG Gene Incontinentia Pigmenti Type 2 Genetic Test This test identifies pathogenic variants in the IKBKG gene associated with Incontinentia Pigmenti type 2.	Whole Blood (Peripheral)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the IKBKG gene", "Point mutations", "Small insertions/deletions", "Copy number variants"] Parameters [] Preparation [] Indications ["Suspected Incontinentia Pigmenti type 2", "Family history of Incontinentia Pigmenti type 2", "Need for definitive molecular diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 55233-1 ICD-10: Q82.3 Clinical summary This test identifies pathogenic variants in the IKBKG gene associated with Incontinentia Pigmenti type 2.
TEST-2912 IL11RA Gene Craniosynostosis and Dental Anomalies Genetic Test This test analyzes the IL11RA gene to detect variants linked to craniosynostosis and dental anomalies.	Peripheral Whole Blood (EDTA) or FTA Card	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the IL11RA gene", "Full coding region sequencing"] Parameters [] Preparation ["Detailed clinical history required", "Pedigree chart of affected family members recommended", "Genetic counseling recommended"] Indications ["Suspected syndromic craniosynostosis", "Family history of IL11RA-related disorders", "Need for definitive molecular diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 55233-1 ICD-10: Q75.0 Clinical summary This test analyzes the IL11RA gene to detect variants linked to craniosynostosis and dental anomalies.
TEST-4860 IL12A Gene (Interleukin 12A Deficiency) Genetic Test This test evaluates the IL12A gene for pathogenic variants associated with interleukin 12A deficiency, a primary immunodeficiency.	Peripheral Whole Blood (3–5 mL EDTA) or Extracted DNA	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the IL12A gene", "Copy Number Variations (CNVs) in the IL12A gene"] Parameters [] Preparation [] Indications ["Suspected primary immunodeficiency", "Recurrent severe infections"] Measurement technique Confirm with laboratory Codes LOINC: 55233-1 ICD-10: D84.8 Clinical summary This test evaluates the IL12A gene for pathogenic variants associated with interleukin 12A deficiency, a primary immunodeficiency.
TEST-4629 IL36RN Gene (Generalized Pustular Psoriasis) Genetic Test This test analyzes the IL36RN gene for pathogenic variants associated with Generalized Pustular Psoriasis (GPP). It identifies mutations that disrupt the function of the interleuki...	Peripheral Whole Blood	3 – 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants (SNVs, indels, CNVs) in the IL36RN gene", "IL-36Ra protein function indirectly"] Parameters [] Preparation ["No specific fasting required", "No medication or diet restrictions"] Indications ["Diagnosis of Generalized Pustular Psoriasis (GPP)", "Differentiation from other pustular dermatoses", "Guiding targeted biologic therapy", "Family counseling for GPP"] Measurement technique Confirm with laboratory Codes LOINC: 94763-4 ICD-10: L40.1 Clinical summary This test analyzes the IL36RN gene for pathogenic variants associated with Generalized Pustular Psoriasis (GPP). It identifies mutations that disrupt the function of the interleukin-36 receptor antagonist (IL-36Ra), leading to uncontrolled skin inflammation.

Category overview

Genetic: overview

Unlocking the blueprint of your DNA provides profound, proactive insights into your family’s future and personal health risks. Integrated within our advanced Biochemistry and molecular services, specialized Genetic testing evaluates inherited traits, metabolic predispositions, and carrier statuses. Utilizing cutting-edge diagnostic technology, comprehensive genetic screening offers the vital clarity needed to safely guide tailored medical strategies and family planning. As an undisputed leader in innovation among diagnostic labs in Dubai and the UAE, DNA Labs guarantees the highest standards of strict patient confidentiality, unparalleled diagnostic precision, and rapid reporting. Empower your health decisions with certainty—book your genetic testing in UAE, coordinate a secure sample collection, or connect with our specialized genetics team today.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.